GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flora Growth Corp (FRA:7301) » Definitions » ROE % Adjusted to Book Value

Flora Growth (FRA:7301) ROE % Adjusted to Book Value : -54.60% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Flora Growth ROE % Adjusted to Book Value?

Flora Growth's ROE % for the quarter that ended in Sep. 2024 was -256.07%. Flora Growth's PB Ratio for the quarter that ended in Sep. 2024 was 4.69. Flora Growth's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -54.60%.


Flora Growth ROE % Adjusted to Book Value Historical Data

The historical data trend for Flora Growth's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flora Growth ROE % Adjusted to Book Value Chart

Flora Growth Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - - - -

Flora Growth Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -54.60

Competitive Comparison of Flora Growth's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Flora Growth's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flora Growth's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Flora Growth's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Flora Growth's ROE % Adjusted to Book Value falls into.



Flora Growth ROE % Adjusted to Book Value Calculation

Flora Growth's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-175.77% / N/A
=N/A

Flora Growth's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-256.07% / 4.69
=-54.60%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Flora Growth ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Flora Growth's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Flora Growth Business Description

Comparable Companies
Traded in Other Exchanges
Address
3406 South West 26th Terrace, Suite C-1, Fort Lauderdale, FL, USA, 33132
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

Flora Growth Headlines

No Headlines